足場技術の市場規模、シェア、成長分析、タイプ別、素材別、疾患タイプ別、用途別、最終用途別、地域別 - 産業予測、2025～2032年

足場技術の世界市場規模は、2023年に19億8,000万米ドルと評価され、2024年の22億5,000万米ドルから2032年には63億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは13.8％で成長する見通しです。

足場技術市場は、危機的な機能不全臓器を持つ患者の増加による臓器移植や再建療法に対する世界の需要の高まりによって、大きな成長を遂げています。組織工学と再生医療では、多くの場合高分子生体材料から作られる足場が細胞に不可欠な構造的支持を提供し、新しい組織の形成を促進します。組織工学の三要素は、細胞、足場、成長因子からなり、足場は繊維状、多孔性、ハイドロゲル型に分類されます。足場の成功は、生体適合性、機械的特性、生分解性といった重要な要素にかかっています。さらに、先進的な3Dマトリックスの開発に向けたバイオテクノロジー企業による研究開発投資の高まりが、市場の進展を後押ししています。全体として、足場技術における技術革新と組織工学への重点の高まりが、この市場の堅調な拡大可能性を裏付けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩

足場技術市場規模：タイプ別

• 市場概要
• ハイドロゲル
  • 傷の治癒
  • 3Dバイオプリンティング
  • 免疫調節
• ポリマー足場
• マイクロパターン表面マイクロプレート
• ナノファイバーベースの足場

足場技術市場規模：素材別

• 市場概要
• バイオ不活性
• 生体吸収性
• バイオアクティブ

足場技術市場規模：疾患タイプ別

• 市場概要
• 整形外科
• 筋骨格
• 脊椎
• がん
• 肌
• 外皮
• 歯科
• 心臓血管学
• 神経学
• 泌尿器科
• 消化器科・婦人科
• その他

足場技術市場規模：用途別

• 市場概要
• 幹細胞療法
• 再生医療
• 組織工学
• がん細胞の調査
• 創薬
• その他

足場技術市場規模：最終用途別

• 市場概要
• バイオテクノロジーおよび製薬組織
• 調査室・研究所
• 病院と診断センター
• その他

足場技術市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific, Inc.（United States）
• Merck KGaA（Germany）
• Tecan Trading AG（Switzerland）
• ReproCELL Inc.（Japan）
• 3D Biotek LLC（United States）
• Becton, Dickinson and Company（United States）
• Medtronic plc（Ireland）
• Corning Incorporated（United States）
• Allergan plc（Ireland）
• Sanofi S.A.（France）
• Avacta Life Sciences Limited（United Kingdom）
• Vericel Corporation（United States）
• Akron Biotech（United States）
• Molecular Matrix, Inc.（United States）
• Matricel GmbH（Germany）
• Pelobiotech GmbH（Germany）
• Xanofi（United States）
• 4titude（United Kingdom）
• Tempo Therapeutics（United States）

結論と推奨事項

Global Scaffold Technology Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.25 billion in 2024 to USD 6.34 billion by 2032, growing at a CAGR of 13.8% during the forecast period (2025-2032).

The scaffold technology market is experiencing significant growth, driven by rising global demand for organ transplants and reconstruction therapies due to an increasing number of patients with critical non-functioning organs. Using tissue engineering and regenerative medicine, scaffolds-often created from polymeric biomaterials-provide essential structural support for cells, facilitating the formation of new tissue. The tissue engineering triad comprises cells, scaffolds, and growth factors, with scaffolds categorized into fibrous, porous, and hydrogel types. The success of scaffolds hinges on crucial factors like biocompatibility, mechanical properties, and biodegradability. Furthermore, heightened R&D investments by biotechnology firms in developing advanced 3D matrices are propelling market advancements. Overall, innovations in scaffold technology and a growing emphasis on tissue engineering underscore this market's robust expansion potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Scaffold Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Scaffold Technology Market Segmental Analysis

Global Scaffold Technology Market is segmented by Type, Material, Disease Type, Application, End-Use and region. Based on Type, the market is segmented into Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds. Based on Material, the market is segmented into Bio-inert, Bioresorbable and Bioactive. Based on Disease Type, the market is segmented into Orthopedics, Musculoskeletal, Spine, Cancer, Skin, Integumentary, Dental, Cardiology & Vascular, Neurology, Urology, GI & Gynecology and Others. Based on Application, the market is segmented into Stem Cell Therapy, Regenerative Medicine, Tissue Engineering, Cancer cell research, Drug Discovery and Others. Based on End-Use, the market is segmented into Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Scaffold Technology Market

The Global Scaffold Technology market is significantly influenced by several key drivers, including the advancement of regenerative technologies and their expanding applications. A rise in accidents leading to organ damage is expected to bolster the need for scaffold technology further. Moreover, the growing aging population may pose a challenge to market growth. Nevertheless, the escalating demand for tissue engineering and reconstructive surgeries, the widespread adoption of biomaterials, along with continuous technological innovations in scaffold technology, are the primary factors propelling the market forward. This combination of demand increase and technological development is essential for the market's success and sustainability.

Restraints in the Global Scaffold Technology Market

The Global Scaffold Technology market faces several constraints impacting its revenue growth during the forecast period. Notably, the rise of scaffold-free methodologies for multi-dimensional cell culture, along with the advancement of matrix-based 3D cellular models, has resulted in mixed outcomes. High implementation costs associated with these technologies further hinder market expansion. Additionally, the introduction of scaffold-free cell culture alternatives is likely to pose a challenge to traditional scaffold solutions. However, there exists significant growth potential in emerging nations, particularly if their governments increase investment in research and development, which could drive innovation and market opportunities in the region.

Market Trends of the Global Scaffold Technology Market

The Global Scaffold Technology market is poised for significant growth driven by advances in synthetic scaffold materials, particularly within tissue engineering. Innovations across genetics, pharmaceuticals, and materials science are aligning to enhance the efficacy and applicability of scaffolds in regenerative medicine. This is particularly critical in addressing the disparity between organ supply and demand for transplantation among patients with terminal conditions. As the need for viable organ alternatives escalates, scaffold technology emerges as a pivotal solution, catalyzing market expansion and attracting investment in research and development, ultimately promising improved patient outcomes and healthcare solutions in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Scaffold Technology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Hydrogels
  • Wound Healing
  • 3D Bioprinting
  • Immunomodulation
• Polymeric Scaffolds
• Micropatterned Surface Microplates
• Nanofiber Based Scaffolds

Global Scaffold Technology Market Size by Material & CAGR (2025-2032)

• Market Overview
• Bio-inert
• Bioresorbable
• Bioactive

Global Scaffold Technology Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Orthopedics
• Musculoskeletal
• Spine
• Cancer
• Skin
• Integumentary
• Dental
• Cardiology & Vascular
• Neurology
• Urology
• GI & Gynecology
• Others

Global Scaffold Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Stem Cell Therapy
• Regenerative Medicine
• Tissue Engineering
• Cancer cell research
• Drug Discovery
• Others

Global Scaffold Technology Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Biotechnology & Pharmaceutical Organizations
• Research Laboratories & Institutes
• Hospitals & Diagnostic Centers
• Others

Global Scaffold Technology Market Size & CAGR (2025-2032)

• North America (Type, Material, Disease Type, Application, End-Use)
  • US
  • Canada
• Europe (Type, Material, Disease Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Material, Disease Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Material, Disease Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Material, Disease Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReproCELL Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3D Biotek LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avacta Life Sciences Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akron Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Matrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matricel GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pelobiotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xanofi (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 4titude (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempo Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations